|
AUPR011700A0
(en)
|
2000-09-14 |
2000-10-05 |
Austin Research Institute, The |
Composition comprising immunogenic virus sized particles (VSP)
|
|
US20140105980A1
(en)
*
|
2012-10-11 |
2014-04-17 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
|
US9522183B2
(en)
|
2010-07-31 |
2016-12-20 |
The Scripps Research Institute |
Compositions and methods for inducing immune tolerance
|
|
EP2603520A4
(en)
|
2010-08-10 |
2014-02-19 |
Ecole Polytech |
ERYTHROCYTE BINDING THERAPEUTICS
|
|
US9517257B2
(en)
|
2010-08-10 |
2016-12-13 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
|
US9850296B2
(en)
|
2010-08-10 |
2017-12-26 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
|
AU2011325966B2
(en)
*
|
2010-11-12 |
2016-09-29 |
Oncour Pharma, Inc. |
Modified immune-modulating particles
|
|
US9511151B2
(en)
|
2010-11-12 |
2016-12-06 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of cancer
|
|
MX374963B
(es)
|
2011-04-29 |
2025-03-06 |
Selecta Biosciences Inc |
Nanoportadores sintéticos tolerogénicos para reducir las respuestas de anticuerpos.
|
|
WO2013036914A1
(en)
*
|
2011-09-08 |
2013-03-14 |
University Of Florida Research Foundation, Inc. |
Materials and methods for modulating immune responses
|
|
US10988516B2
(en)
|
2012-03-26 |
2021-04-27 |
Uti Limited Partnership |
Methods and compositions for treating inflammation
|
|
US9597385B2
(en)
|
2012-04-23 |
2017-03-21 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
|
WO2013184976A2
(en)
*
|
2012-06-06 |
2013-12-12 |
Northwestern University |
Compositions and methods for antigen-specific tolerance
|
|
CN110064049B
(zh)
|
2012-06-21 |
2024-02-09 |
西北大学 |
肽缀合粒子
|
|
US9603948B2
(en)
|
2012-10-11 |
2017-03-28 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
|
US11439594B2
(en)
|
2012-12-04 |
2022-09-13 |
Phosphorex, Inc. |
Microparticles and nanoparticles having negative surface charges
|
|
EP3494966B1
(en)
*
|
2013-03-13 |
2024-04-03 |
onCOUR Pharma, Inc. |
Immune-modifying particles for the treatment of inflammation
|
|
KR102233251B1
(ko)
|
2013-04-03 |
2021-03-26 |
엔-폴드 엘엘씨 |
신규 나노입자 조성물
|
|
BR122020023215B1
(pt)
|
2013-05-03 |
2022-11-22 |
Selecta Biosciences, Inc |
Composição e kit de nanocarreadores sintéticos tolerogênicos para reduzir ou prevenir anafilaxia em resposta a um antígeno não alergênico
|
|
BR112015030237A2
(pt)
|
2013-06-04 |
2017-10-03 |
Selecta Biosciences Inc |
Imunoterapêutico antígeno-específico, composição, método de fabricação e seu uso
|
|
CN105555303A
(zh)
*
|
2013-06-28 |
2016-05-04 |
贝勒研究院 |
用于多发性硬化症的树突细胞asgpr靶向免疫治疗剂
|
|
KR20160042079A
(ko)
|
2013-08-13 |
2016-04-18 |
노쓰웨스턴유니버시티 |
펩티드-접합된 입자
|
|
AU2014343379B2
(en)
|
2013-11-04 |
2019-02-14 |
Uti Limited Partnership |
Methods and compositions for sustained immunotherapy
|
|
US10953101B2
(en)
|
2014-02-21 |
2021-03-23 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
|
SG11201606761RA
(en)
|
2014-02-21 |
2016-09-29 |
Ecole Polytecnique Federale De Lausanne Epfl Epfl Tto |
Glycotargeting therapeutics
|
|
US10046056B2
(en)
|
2014-02-21 |
2018-08-14 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
|
US10946079B2
(en)
|
2014-02-21 |
2021-03-16 |
Ecole Polytechnique Federale De Lausanne |
Glycotargeting therapeutics
|
|
JP7242180B2
(ja)
*
|
2014-09-07 |
2023-03-20 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
抗ウイルス導入ベクター免疫応答を減弱化するための方法および組成物
|
|
JP6692834B2
(ja)
|
2015-02-09 |
2020-05-13 |
スリングショット バイオサイエンシーズ， インコーポレイテッド |
調整可能な光学特性を有するヒドロゲル粒子およびその使用の方法
|
|
EP3291832B1
(en)
|
2015-05-06 |
2025-09-03 |
UTI Limited Partnership |
Nanoparticle compositions for sustained therapy
|
|
JP7194593B2
(ja)
|
2015-12-23 |
2022-12-22 |
クール ファーマシューティカルズ ディベロップメント カンパニー インコーポレイテッド |
共有ポリマー抗原コンジュゲート化粒子
|
|
EP3445332B1
(en)
*
|
2016-04-18 |
2022-04-27 |
University of Maryland, College Park |
Harnessing quantum dots to study, visualize, and promote immune tolerance
|
|
ES3036482T3
(en)
|
2017-03-11 |
2025-09-19 |
Cartesian Therapeutics Inc |
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
|
|
WO2018232176A1
(en)
|
2017-06-16 |
2018-12-20 |
The University Of Chicago |
Compositions and methods for inducing immune tolerance
|
|
JP7270946B2
(ja)
*
|
2017-08-08 |
2023-05-11 |
国立大学法人浜松医科大学 |
自己免疫疾患の治療又は予防剤
|
|
CA3083748A1
(en)
|
2017-11-29 |
2019-06-06 |
Uti Limited Partnership |
Methods of treating autoimmune disease
|
|
EP3790577A4
(en)
|
2018-05-09 |
2022-04-27 |
The University of Chicago |
COMPOSITIONS AND METHODS RELATED TO IMMUNTOLERANCE
|
|
AU2020287627A1
(en)
|
2019-06-04 |
2021-11-18 |
Selecta Biosciences, Inc. |
Formulations and doses of PEGylated uricase
|
|
US20230001010A1
(en)
*
|
2019-07-19 |
2023-01-05 |
The Regents Of The University Of Michigan |
Compositions and methods for treating autoimmune disorders
|
|
WO2021041874A1
(en)
|
2019-08-29 |
2021-03-04 |
Martin David C |
Biofunctional thiophene monomers
|
|
FI20215508A1
(en)
|
2020-04-09 |
2021-10-10 |
Niemelae Erik Johan |
Mimetic nanoparticles to prevent the spread of new coronaviruses and reduce the rate of infection
|
|
US12194157B2
(en)
|
2020-04-09 |
2025-01-14 |
Finncure Oy |
Carrier for targeted delivery to a host
|
|
WO2022235125A1
(ko)
*
|
2021-05-06 |
2022-11-10 |
서울대학교 산학협력단 |
항체 및 자가항원이 표면에 결합된 지질-생체고분자 나노입자 및 이의 용도
|
|
CN119907921A
(zh)
|
2022-05-05 |
2025-04-29 |
弹弓生物科学公司 |
用于血液学的作为红细胞模拟物的工程化颗粒和含有工程化颗粒的组合物
|
|
CA3257621A1
(en)
|
2022-06-02 |
2023-12-07 |
Slingshot Biosciences, Inc. |
APOPTOTIC CELL MIMETIC
|
|
WO2024182722A1
(en)
*
|
2023-03-01 |
2024-09-06 |
Georgia Tech Research Corporation |
Therapeutic nanoparticles for solid organ immune acceptance
|